Loading...
603983 logo

Guangdong Marubi Biotechnology Co., Ltd.SHSE:603983 Stock Report

Market Cap CN¥8.6b
Share Price
CN¥21.37
CN¥30.57
30.1% undervalued intrinsic discount
1Y-54.1%
7D-6.0%
1D
Portfolio Value
View

Guangdong Marubi Biotechnology Co., Ltd.

SHSE:603983 Stock Report

Market Cap: CN¥8.6b

Guangdong Marubi Biotechnology (603983) Stock Overview

Engages in the research and development, design, production, sale, and service of various cosmetics in China. More details

603983 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance2/6
Financial Health5/6
Dividends2/6

603983 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Guangdong Marubi Biotechnology Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Guangdong Marubi Biotechnology
Historical stock prices
Current Share PriceCN¥21.37
52 Week HighCN¥47.67
52 Week LowCN¥21.20
Beta0.23
1 Month Change-17.59%
3 Month Change-22.12%
1 Year Change-54.14%
3 Year Change-38.61%
5 Year Change-59.60%
Change since IPO-27.76%

Recent News & Updates

Recent updates

Analysis Article Apr 01

If EPS Growth Is Important To You, Guangdong Marubi Biotechnology (SHSE:603983) Presents An Opportunity

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Mar 16

A Look At The Fair Value Of Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983)

Key Insights The projected fair value for Guangdong Marubi Biotechnology is CN¥38.41 based on 2 Stage Free Cash Flow to...
Analysis Article Dec 25

Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
Analysis Article Dec 09

Calculating The Fair Value Of Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983)

Key Insights Guangdong Marubi Biotechnology's estimated fair value is CN¥31.88 based on 2 Stage Free Cash Flow to...
Analysis Article Nov 22

Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article Sep 26

Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Those holding Guangdong Marubi Biotechnology Co., Ltd. ( SHSE:603983 ) shares would be relieved that the share price...
Analysis Article Aug 30

Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Despite announcing strong earnings, Guangdong Marubi Biotechnology Co., Ltd.'s ( SHSE:603983 ) stock was sluggish. Our...
Analysis Article Jun 19

Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...
Analysis Article May 29

Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article May 07

Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

Key Insights The projected fair value for Guangdong Marubi Biotechnology is CN¥24.06 based on 2 Stage Free Cash Flow to...
Analysis Article Mar 27

Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

With a price-to-earnings (or "P/E") ratio of 51.8x Guangdong Marubi Biotechnology Co., Ltd. ( SHSE:603983 ) may be...
Analysis Article Feb 29

Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Shareholder Returns

603983CN Personal ProductsCN Market
7D-6.0%-4.0%-3.7%
1Y-54.1%-29.6%25.6%

Return vs Industry: 603983 underperformed the CN Personal Products industry which returned -29.6% over the past year.

Return vs Market: 603983 underperformed the CN Market which returned 25.6% over the past year.

Price Volatility

Is 603983's price volatile compared to industry and market?
603983 volatility
603983 Average Weekly Movement4.2%
Personal Products Industry Average Movement5.1%
Market Average Movement6.6%
10% most volatile stocks in CN Market10.4%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 603983 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 603983's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021,380Huaiqing Sunwww.marubi.cn

Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company offers eye care, skincare, cleansing, and beauty and other products. It sells its products under the Marubi, Lianhuo, Chunji, and Passional Lover brands.

Guangdong Marubi Biotechnology Co., Ltd. Fundamentals Summary

How do Guangdong Marubi Biotechnology's earnings and revenue compare to its market cap?
603983 fundamental statistics
Market capCN¥8.57b
Earnings (TTM)CN¥213.21m
Revenue (TTM)CN¥3.49b
40.2x
P/E Ratio
2.5x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603983 income statement (TTM)
RevenueCN¥3.49b
Cost of RevenueCN¥920.79m
Gross ProfitCN¥2.57b
Other ExpensesCN¥2.36b
EarningsCN¥213.21m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.53
Gross Margin73.65%
Net Profit Margin6.10%
Debt/Equity Ratio13.4%

How did 603983 perform over the long term?

See historical performance and comparison

Dividends

2.3%
Current Dividend Yield
94%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/11 03:19
End of Day Share Price 2026/06/11 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guangdong Marubi Biotechnology Co., Ltd. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Melinda HuBernstein
Lei YangCGS International
Lei YangChina Galaxy International Securities (Hong Kong)